Patient finding is broken.
So are the solutions.

Until now…

Ambit is reimagining patient finding in specialty and rare diseases with a comprehensive approach that identifies and engages both patients and HCPs through a combination of advanced analytics, omnichannel marketing and direct outreach through our team of Ambit Guides.

Let us show you how Dynamic LeadGen and Patient Activate can impact your business.

By utilizing AI/ML modeling and algorithmic triggers, omnichannel activation and continuous measurement, Dynamic LeadGen is transforming HCP targeting in rare and specialty diseases – empowering biopharma to disrupt current sub-optimal approaches to patient finding.

The Difference is Clear.

LEGACY SOLUTIONS

STALE LEADS

The lag time inherent in claims data poses challenges, especially for rare diseases where patient interactions with HCPs might be infrequent – leaving field teams chasing outdated leads.

LOW YIELDS

Only a fraction of the leads generated by traditional trigger models yield patients due to the limited reach of small, over-taxed field forces – leaving valuable opportunities untapped.

BLACK BOX

Traditional trigger-based models do not measure ROI or yield because they are limited to a file hand-off of retrospective claims analysis.

PREDICTIVE & TIMELY

Dynamic LeadGen forecasts where patients will go next by leveraging the power of ML/AI to map referral networks – empowering biopharma to engage with healthcare providers proactively.

EXPANDED REACH

Dynamic LeadGen extracts incremental value from claims data analysis through NPI-powered media – extending coverage to target HCPs beyond the reach of traditional sales teams.

ALWAYS-ON MEASUREMENT

Dynamic LeadGen continuously measures the effectiveness of engagement by tracking a patient’s downstream actions.

Patient Activate simplifies patient identification for biopharma companies, providing a complete, compliant solution for finding and activating specialty and rare disease patients.

The Difference is Clear.

LEGACY SOLUTIONS

INEFFICIENT TARGETING

Digital media programs struggle to efficiently reach small and dispersed patient populations – instead relying on traditional targeting approaches.

SELF-GUIDED

Overwhelmed patients and caregivers are on their own to research a potential diagnosis by navigating websites, signing up for email programs, and bringing information to doctors.

VANITY METRICS

Traditional KPIs, such as impression delivery, website traffic, email sign-ups, and content consumption, offer limited insights, particularly in the context of rare diseases where patient populations are small.

DATA DRIVEN

Patient Activate leverages a data-driven understanding of the digital patient journey to seamlessly guide patients and caregivers to an opt-in platform.

HIGH-TOUCH

Patient Activate provides dedicated Ambit Guides who work directly with patients, parents, or caregivers to navigate the information and the diagnostic journey.

MEANINGFUL MEASUREMENT

Patient Activate moves away from superficial metrics like website views and email sign-ups. Instead, it focuses on meaningful outcomes, such as the identification and activation of qualified, consented patients.

Accelerating the path to diagnosis and treatment.

100 days

Average Reduction

Ambit’s Patient ID & Activation solutions reduced the rare disease diagnostic journey by about 100days on average.

Increased Yield

Implementation of patient identification tactics to fill current gaps resulted in 6X expected yield within the first 2 months of a project.

2 days

Faster Conversion

Patient Active and 1:1 support resulted in an average activation to conversion time of 2 days for qualified leads.

50%

Reduced Dropout

With a high touch patient support model by Ambit Guides, dropout of eligible patients had been reduced by 50%.

Solutions in Action

Watch this video to see how Dynamic LeadGen and Patient Activate work together to provide a novel, scalable and proven approach to Patient Identification and Activation.

Enhancing Patient Outcomes Daily

“When I qualified for genetic services and knew that I had someone to talk with, it was much more comforting to me…it was clear what Ambit was going to provide to me.”

Caregiver

“My Ambit Guide was wonderful, she helped me upload documents and understand what the process would look like.”

Caregiver

“I am grateful for Ambit and the ability to now understand my child’s [genetic test] results.”

Caregiver

“The support in the beginning to set up the genetic counseling appointment was very easy and effortless. I felt like the Ambit Guide really heard me.”

Caregiver

“Seeing the Patient Activate team working hard for me was amazing.”

Caregiver

“I had somebody who had a pathogenic result and when I called [the caregiver] to talk about it, she said she already had an appointment with you guys for tomorrow for genetic counseling. I was impressed by the speed of that and thought that was well-coordinated.”

Partner HCP

FREQUENTLY ASKED QUESTIONS

What’s the difference between Dynamic LeadGen and Patient Activate?

Dynamic LeadGen is our HCP-focused product. It leverages AI/ML-driven predictive modeling and algorithmic triggers to provide timely, high-quality HCP leads for your field force.

Patient Activate is our direct-to-patient/caregiver product. It is a comprehensive, fully-compliant patient finding solution for biopharma companies working to navigate the challenges of identifying specialty and rare disease patients.

Do I need to buy both products?

Not at all. Each product is available on its own and can be configured to meet your needs. However, the benefits of combining both products is significant.

Who is Ambit?

Founded in 2020, Ambit is a technology-enabled solutions company focused on rare and specialty diseases. We provide custom strategic services and advanced data analytics and offer a range of data products – where we aim to solve recuring biopharma challenges at scale.

How is Patient Activate different than a traditional DSE program?

Unlike traditional DSE programs, Patient Activate is 100% focused on delivering qualified, consented patients to our clients for clinical trials or approved therapies. Patient Activate goes beyond simply driving potential patients to an informational website. Its tailored, data-driven understanding of the digital patient journey and team of Ambit Guides efficiently steer hard-to-find patients through the diagnostic journey and compliantly hand off qualified and consented patients to our biopharma partners.

What if I already have a DSE program running?

Not a problem! Patient Activate can provide beneift in addition to your DSE website. Ambit works with agencies and clients to develop the best approach to operationalizing.

Patient Activate can supplement existing campaigns by elevating the call to action on your DSE website. We can embed the custom assessment on your DSE website and manage the inbound patient inquiries.

How does this program impact my agency relationship?

We collaborate with agency partners all the time on things like keyword research, media planning, and content development. While we can execute these tasks independently, Ambit is not an agency so we are happy to collaborate with your agency partner.

How do you manage patient privacy and compliance?

Our Ambit Guides are trained to capture patient consent at every step of the journey.

How long does it take to implement?

Patient Activate can be up and running in 4-6 weeks!

How does Dynamic LeadGen differ from the competitors?

Dynamic LeadGen differs from traditional trigger-based claims programs in 3 important ways.

Bolstered by AI/ML-powered predictive modeling of referral patterns, Dynamic LeadGen predicts where patients will go next — a valuable insight for hard-to-diagnosis conditions.
Dynamic LeadGen extracts incremental value from the claims analysis by enabling NPI-powered media to extend coverage to target HCPs not accessible by the sales team.
Dynamic LeadGen is the only solution on the market with end-to-end measurement capabilities to evaluate the impact of the claims analysis from patient identification through diagnosis and treatment.